latest news releases from the newsroom
Alfa Laval Provides Heat Exchangers to Kuwait for Cleaning Crude Oil
STOCKHOLM, Sweden, Nov. 17, 2005 (PRIMEZONE) -- Alfa Laval -- a world leader in heat transfer, centrifugal separation and fluid handling -- has received an order of approximately SEK 100 million for plate heat exchangers and utilities from Korean contractor SK Engineering & Construction (SKEC). Delivery of the equipment is planned for 2007.
Pharming Group N.V.
Pharming Presents rhC1INH Update at International Meetings
LEIDEN, Netherlands, Nov. 17, 2005 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHARM.AS) announced today that the Company presented clinical results of recombinant human C1 inhibitor (rhC1INH) at several international meetings, including the CHAES Annual General Meeting and Conference in Montreal, Canada, the AAEE Meeting in Rome, Italy and the ACAAI Annual Meeting in Anaheim, USA.
Actelion and UCB Enter Into Assignment and License Agreement for Zavesca(miglustat)
BRUSSELS, Belgium and ALLSCHWIL, Switzerland, Nov. 17, 2005 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) and UCB (Euronext:UCB) today announced that the two companies have replaced their existing license agreement with immediate effect covering Zavesca(r) (miglustat), an orally active therapeutic medicine that is currently approved in the European Union, the United States, Canada, Israel and Switzerland for the treatment of adult patients with mild to moderate Gaucher type 1 disease, where Enzyme Replacement Therapy (ERT) is not suitable or not an option.
Actelion and UCB Enter Into Assignment and License Agreement for Zavesca -- miglustat
ALLSCHWIL, Switzerland and BRUSSELS, Belgium, Nov. 17, 2005 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) (Other OTC:ALIOF) and UCB (Euronext: UCB, UCBBt.RR, UCB BB) today announced that the two companies have, with immediate effect, replaced their existing license agreement covering Zavesca(r) (miglustat), an orally active therapeutic medicine that is currently approved in the European Union, the United States, Canada, Israel and Switzerland for the treatment of adult patients with mild to moderate Gaucher type 1 disease, for whom Enzyme Replacement Therapy (ERT) is not suitable or not a therapeutic option.
CDMA Development Group
CDMA2000 Celebrates Five Years of Leadership in the Industry's Transition To 3G and Next Generation Wireless Services
HONG KONG, Nov. 16, 2005 (PRIMEZONE) -- In his keynote address at the 3G World Congress, Perry LaForge, executive director of the CDMA Development Group (CDG) (www.cdg.org) announced that with 200 million subscribers in 61 countries, CDMA2000(R) is the fastest expanding technology and delivers advanced voice and data services to people across all markets, creating new market and revenue opportunities for operators. CDMA2000 is the most advanced 3G technology deployed today and its evolution path offers operators at least two years' lead in the introduction of enhanced capabilities and services.
Law Offices of Howard G. Smith
Notice of Filing Securities Class Action Against Spectrum Brands, Inc. -- SPC
BENSALEM, Pa., Nov. 16, 2005 (PRIMEZONE) -- Smith & Smith LLP announces that a securities class action lawsuit has been filed on behalf of shareholders who purchased securities of Spectrum Brands, Inc. ("Spectrum" or the "Company")(NYSE:SPC), between January 4, 2005 and November 11, 2005, inclusive (the "Class Period"). The class action lawsuit was filed in the United States District Court for the Northern District of Georgia.
HCC Insurance Holdings, Inc.
HCC Estimates Wilma Loss
HOUSTON, Nov. 16, 2005 (PRIMEZONE) -- HCC Insurance Holdings, Inc. (NYSE:HCC) advised today that anticipated gross claims from Hurricane Wilma are estimated at $30 million arising from aviation, property and other specialty lines of business. The net loss after reinsurance and including reinsurance reinstatement costs is estimated at $13.0 million after tax which will reduce fourth quarter earnings of the Company by approximately $0.12 per diluted share. This amount could be considerably less depending on how previous hurricane losses affect the Company's sophisticated reinsurance protection.
Penn's Landing Corporation
A Sparkling New Year's Eve With Fireworks at Penn's Landing -- the New Year's Eve Party on Ice
PHILADELPHIA, Nov. 16, 2005 (PRIMEZONE) -- Fireworks at Penn's Landing are a grand New Year's Eve tradition and The New Year's Eve Party on Ice at the Blue Cross RiverRink is a fun-filled way to celebrate. It's great for all ages and ideal for families as a non-alcoholic way to ring in the New Year. The Blue Cross RiverRink's new and convenient location on Columbus Boulevard at Market Street will be the perfect place to view the Midnight fireworks over the Delaware River. Great food, fun activities, and live entertainment in the heated facility, along with ice-skating make this party one of the most unique in Philadelphia!